G6PD and malaria: In 2011, the Myanmar National Malaria Control Program (NMCP) introduced PQ to the National Antimalaria Treatment Policy, which recommended that a 3-day chloroquine together with a 14-day PQ (0.25mg/kg/day) be given to patients with P. vivax malaria by BHS without glucose 6 phosphate dehydrogenase (G6PD) testing.